This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

ROBERT DEAN MATTIS, M.D.

Arch Ophthal. 1941;26(6):969-982.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Myasthenia gravis, so named by Jolly¹ in 1895, is clinically characterized by a syndrome which includes weakness, fatigue and in some cases actual wasting away of muscles without any pathologic changes microscopically demonstrable as specific to the disease.

There seems to be a predisposition for involvement of groups of muscles innervated by cranial nerves.

The causation is unknown, but it is believed that there is such an insufficiency of acetylcholine or some like substance at the myoneural junction that the neuromotor impulse is not transmitted across the junction. It has been postulated that this fault is caused either by underproduction of the choline-like substance at the motor end plates or by an accelerated disposal of it by an overabundance of acetylcholine esterase, a substance whose normal function is to destroy acetylcholine.²

This disease is no regarder of sex, approximately equal numbers of males and of females being affected. . . . [Full Text PDF of this Article]

Author Affiliations
BOSTON

From the Department of Ophthalmology, Massachusetts Eye and Ear Infirmary ; as paper number 14, from the Myasthenia Gravis Clinic of the Department of Neurology, Massachusetts General Hospital, and from Harvard Medical School.

Footnotes
Read before the New England Ophthalmological Society, Dec. 17, 1940.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?